Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy.

MLA

Baech, Joachim, et al. “Risk of Diabetes and the Impact on Preexisting Diabetes in Patients with Lymphoma Treated with Steroid-Containing Immunochemotherapy.” Blood Advances, vol. 6, no. 15, Aug. 2022, pp. 4427–35. EBSCOhost, https://doi.org/10.1182/bloodadvances.2021006859.

APA

Baech, J., Severinsen, M. T., Øvlisen, A. K., Frederiksen, H., Vestergaard, P., Torp-Pedersen, C., Jørgensen, J., Clausen, M. R., Poulsen, C. B., Brown, P., Gang, A. O., Pedersen, R. S., Ekström Smedby, K., Eloranta, S., Jakobsen, L. H., & El-Galaly, T. C. (2022). Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy. Blood Advances, 6(15), 4427–4435. https://doi.org/10.1182/bloodadvances.2021006859

Chicago

Baech, Joachim, Marianne Tang Severinsen, Andreas K Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit Jørgensen, et al. 2022. “Risk of Diabetes and the Impact on Preexisting Diabetes in Patients with Lymphoma Treated with Steroid-Containing Immunochemotherapy.” Blood Advances 6 (15): 4427–35. doi:10.1182/bloodadvances.2021006859.